Introduction: The Erosion of a Decades-Long Partnership
The relationship between the United States of America and the World Health Organization (WHO) stands at a precarious crossroads. For over seven decades, the United States has served not merely as a founding member of the UN’s specialized health agency, but as a cornerstone of its operational and financial architecture. Together, the two entities have celebrated historic triumphs, from the total eradication of smallpox to the systematic containment of HIV, Ebola, and polio.
However, the recent decision by the U.S. government to formally notify the organization of its intent to withdraw has sent shockwaves through the global public health community. WHO leadership, in a series of formal statements, has expressed deep regret over this departure, characterizing the move as one that compromises the collective safety of the global population. As the international community prepares for upcoming deliberations at the WHO Executive Board and the World Health Assembly, the tension between the world’s largest superpower and the preeminent global health authority has moved to the forefront of international diplomacy.
The Core Disagreements: Allegations and Counter-Allegations
The rift, while complex, is primarily rooted in the U.S. government’s sharp criticism of the WHO’s management of the COVID-19 pandemic. Washington has leveled serious accusations against the agency, alleging that the WHO "trashed and tarnished" its reputation, succumbed to a "politicized, bureaucratic agenda," and failed to maintain independence from external political pressures.
Specifically, the U.S. has accused the WHO of "obstructing the timely and accurate sharing of critical information" and actively "concealing" organizational failures during the early months of the SARS-CoV-2 outbreak.
The WHO, for its part, has categorically rejected these assertions. In a detailed rebuttal, the agency emphasizes that it has consistently sought to engage with the United States in good faith, maintaining a policy of impartial service to all 194 Member States. The WHO argues that the allegation of a "politicized agenda" is fundamentally at odds with its mandate as a UN agency, which operates on the principle of sovereign equality. According to the organization, the accusation that it serves "nations hostile to American interests" is a distortion of the collaborative nature of international health governance, where the agency must balance the interests of a diverse global membership.
Chronology: The First Days of the COVID-19 Crisis
To understand the divergence in perspective, one must revisit the critical early stages of the pandemic. The WHO maintains that its response was characterized by speed, transparency, and reliance on the best available empirical evidence.
- 31 December 2019: The WHO receives the first official reports of a cluster of "pneumonia of unknown cause" in Wuhan, China. The agency immediately activates its emergency incident management system and requests further clarification from Chinese authorities.
- 11 January 2020: As the first death is reported in China, the WHO alerts the global community through formal notification channels, public statements, and social media. It begins convening global experts to formulate guidance.
- 30 January 2020: The WHO Director-General declares COVID-19 a "Public Health Emergency of International Concern" (PHEIC). At this juncture, fewer than 100 cases—and zero deaths—had been reported outside of China.
- Early 2020: The Director-General repeatedly warns the international community that the "window of opportunity is closing," famously declaring that the virus was "public enemy number one" and asserting that the situation was "not a drill."
The WHO maintains that it provided comprehensive guidance on protection measures, such as the use of masks, physical distancing, and vaccination. Crucially, the organization notes that at no point did it issue global mandates for lockdowns or vaccines, emphasizing that these sovereign decisions were left to individual governments based on their own risk assessments.
Supporting Data: Governance and Structural Integrity
The WHO’s defense rests on its structural independence. As a specialized agency of the United Nations, it is governed by a collective of 194 Member States. The agency argues that its performance reviews, which were conducted following the pandemic, have resulted in a significant strengthening of its internal mechanisms.
These mechanisms, which operate on a 24/7 basis, are designed to monitor and mitigate health threats before they escalate into global crises. By continuously refining its preparedness and response capacities, the WHO asserts that it has remained a vital pillar of defense for all countries—including the United States. The organization points to its ongoing work in non-communicable diseases, antimicrobial resistance, and food safety as evidence of its continued relevance and functionality, regardless of the political disputes currently complicating its relationship with Washington.
The Future of Global Health Governance
Despite the current diplomatic fallout, the WHO continues to look toward long-term systemic improvements. Last year, Member States reached a milestone by adopting the WHO Pandemic Agreement, a landmark legal instrument intended to bolster international cooperation in the face of future biological threats.
Currently, negotiations are underway for an annex to this agreement: the Pathogen Access and Benefit Sharing (PABS) system. If successfully adopted, this system will revolutionize how the world detects, tracks, and shares information about pathogens with pandemic potential. It is designed to ensure equitable access to diagnostics, therapeutics, and vaccines, addressing one of the most glaring failures of the COVID-19 response: the inequitable distribution of medical countermeasures.
Implications: A World Less Safe?
The departure of a founding member like the United States carries significant implications. Beyond the financial impact, there is the question of scientific and strategic collaboration. The WHO relies on the technical expertise, data sharing, and public health infrastructure of its members. The absence of the U.S. from the decision-making table risks creating a vacuum in global health leadership and weakens the collective ability of the international community to respond to emerging threats.
The U.S. government’s notification of withdrawal is scheduled to be a primary topic of discussion during the WHO Executive Board meeting in February and the World Health Assembly in May 2026. These meetings will serve as a venue for legal and diplomatic deliberations, as the international community attempts to navigate the potential loss of one of its primary contributors.
Conclusion: The Door Remains Open
The WHO’s official stance remains one of pragmatic hope. While the agency expresses profound disappointment, it has repeatedly signaled that the door remains open for the United States to return to active participation.
The WHO’s core mission—to ensure the "highest attainable standard of health as a fundamental right for all people"—remains unchanged by the shifting political tides. In its final statements on the matter, the organization emphasizes its steadfast commitment to its constitutional mandate. Whether the global health architecture can weather this storm remains to be seen, but the WHO maintains that the challenges of the 21st century—be they pandemics, climate-related health crises, or the rise of antibiotic resistance—are simply too great for any nation to address in isolation. As the world moves forward, the hope among the remaining Member States is that the spirit of international cooperation will eventually prevail over the current state of geopolitical friction.
About the Author
